Skip to main content
Clinical Trials/NCT05579717
NCT05579717
Completed
N/A

Examining the Effectiveness of Equine Assisted Learning for Trauma-exposed Public Safety Personnel

McMaster University1 site in 1 country40 target enrollmentMarch 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
McMaster University
Enrollment
40
Locations
1
Primary Endpoint
PTSD symptomatology
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

This quasi-experiment will evaluate the effectiveness of Equine Assisted Learning for reducing symptoms associated with trauma exposure among public safety personnel (e.g., fire fighters, police, paramedics, etc.).

Detailed Description

The purpose of the proposed project is to investigate the effectiveness of Equine Assisted Learning (EAL) for reducing symptoms associated with trauma exposure among public safety personnel. EAL is an intervention in which mental health clinicians and equine specialists work together with clients to address a learning goal via unmounted interaction with a horse. Recent literature indicates that EAL shows promise in addressing a range of mental health diagnoses among a variety of populations, including military and Royal Canadian Mounted Police veterans with PTSD. The EAL intervention will be delivered at Cartier Farms in Spruce Home, Saskatchewan. Research components of this study will be conducted virtually via Zoom. The investigators will employ a quasi-experimental design with pre-post and follow-up testing. Participants will be assigned one of two groups based on the time that they complete their initial baseline interview: (1) the intervention group will receive the EAL intervention for 8 weeks, while (2) the waitlist control condition will not receive this treatment for the same amount of time. Data on trauma exposure symptom severity will be collected from all participants prior to the start of the the study (baseline), again 8 weeks later (post), and then a final time 3 months later (follow-up). The two conditions will then be compared to determine whether there are differences in trauma exposure symptom severity between groups. To obtain a sufficient sample size while also running appropriately sized interventions of 6-10 participants per session, the researchers will conduct 4-6 rounds of group assignment. All individuals in the waitlist control condition will be offered EAL following their completion of the study.

Registry
clinicaltrials.gov
Start Date
March 1, 2022
End Date
August 31, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Margaret McKinnon

Professor

McMaster University

Eligibility Criteria

Inclusion Criteria

  • English-speaking adults;
  • Currently or previously employed as public safety personnel (e.g., police officer, fire fighter, paramedic, healthcare worker, emergency dispatcher, correctional officer);
  • Reside in Saskatchewan;
  • Meet diagnostic criteria for having experienced a Criterion A traumatic event;
  • Able to provide written informed consent;
  • Have access to a smart phone, tablet, or computer with a working microphone and camera; and
  • Have access to consistent and reliable internet.
  • Meet/met current/past diagnostic criteria for several psychiatric, neurodevelopmental, and neurological conditions;
  • History of severe head trauma with loss of consciousness or history of traumatic brain injury;
  • Have previously completed at least half of the EAL curriculum at Cartier Farms.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

PTSD symptomatology

Time Frame: 20 weeks

Changes in performance on the PTSD Checklist for DSM-5 at pre, post, and follow-up. Scores can range between 0 and 80 with higher scores denoting higher PTSD symptomatology.

Secondary Outcomes

  • Mental health symptomatology(20 weeks)
  • Depression, anxiety, and stress symptomatology(20 weeks)
  • Substance involvement(20 weeks)
  • Health complaints(20 weeks)
  • Sleep quality(20 weeks)
  • Body awareness(20 weeks)
  • Moral injury(20 weeks)
  • Dissociation(20 weeks)
  • Emotion regulation(20 weeks)
  • Exposure to childhood trauma(Completed once at baseline)
  • Alcohol use disorder symptomatology(20 weeks)
  • Cannabis use disorder symptomatology(20 weeks)
  • Substance use disorder symptomatology(20 weeks)
  • Resilience(20 weeks)
  • Self-compassion(20 weeks)
  • Health and disability(20 weeks)
  • Disability(20 weeks)
  • Work functioning and productivity(20 weeks)

Study Sites (1)

Loading locations...

Similar Trials